Pathophysiology of lymphedema-Is there a chance for medication treatment?

J Surg Oncol. 2017 Jan;115(1):96-98. doi: 10.1002/jso.24414. Epub 2016 Aug 26.

Abstract

Lymphedema is a common morbid after cancer treatment. The disease characterizes with progressive inflammatory process that result in irreversible fibrosis. Its chronology and progressive disease character often impacts the quality of life of cancer survivors. The pathophysiology of lymphedema remains unclear and the disease remains non-curable. In this article, we reviewed available studies of lymphedema and concluded possible treatment strategies for lymphedema. J. Surg. Oncol. 2017;115:96-98. © 2016 Wiley Periodicals, Inc.

Keywords: T-cell; inflammation; lymphedema.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Lymphedema / drug therapy*
  • Lymphedema / physiopathology*